Author

Bishal Singh

Institution: CT University

Observed institution: CT University

ORCID: 0009-0005-8195-0327

Observed ORCID: 0009-0005-8195-0327

OpenAlex ID: A5138955377

Lymphatic–Targeted Nanoparticle Drug Delivery for Early Cancer Metastasis and Lymphoma: Bypassing Hepatic First–Pass Metabolism

2026 · Bishal Singh, Abhisekh Sah, et al. · Nano LIFE · 1

From Biomimicry to Translational Readiness: Barrier-Centric Design Principles for Intracellular Protein and Genome-Editing RNP Nanodelivery

2026 · Bishal Singh, Abhisekh Sah, et al. · Nano LIFE

Beyond Nanosizing: Mechanism-Guided Design and Rational Selection of Polymeric and Lipid Nanocarriers for Translatable Drug Delivery

2026 · Bishal Singh, Abhisekh Sah, et al. · DARU Journal of Pharmaceutical Sciences

Toward AI-integrated Digital Twin Frameworks for Nanocarrier-Mediated CRISPR Gene Editing: A Perspective

2026 · Abhisekh Sah, Bishal Singh, et al. · Nano LIFE

Wearable hydrogel-integrated microfluidic platforms for controlled cutaneous and transdermal drug delivery: engineering design, stimuli-responsive release, and computational modeling

2026 · Abhisekh Sah, Bishal Singh, et al. · Biomedical Microdevices

Associating Tea Bioactivity to Cardiovascular Protection: Mechanisms and Therapeutic Potential

2026 · Bishal Singh, Divyanshi Sharma, et al. · Current Hypertension Reviews

Works count: 6

Citation count: 1

H-index: 1

I10-index: